Neoadjuvant therapy is associated with lower margin positivity rates after Pancreaticoduodenectomy in T1 and T2 pancreatic head cancers: An analysis of the National Cancer Database

Neoadjuvant therapy is associated with lower margin positivity rates after Pancreaticoduodenectomy in T1 and T2 pancreatic head cancers: An analysis of the National Cancer Database

Background: Neoadjuvant therapy (NAT) for T1/T2 pancreatic adenocarcinoma (PDAC) prior to pancreaticoduodenectomy remains controversial. We compared positive margin rates in patients with clinical T1&T2 tumors who did and did not receive NAT. Methods: The National Cancer Database (NCDB) found cl...

Full description

Bibliographic Details
Main Authors: Stephanie H. Greco, MD, David A. August, MD, Mihir M. Shah, MD, Chunxia Chen, MS, Dirk F. Moore, PhD, Monika Masanam, BA, Amber L. Turner, MPH, Salma K. Jabbour, MD, Parisa Javidian, MD, Miral S. Grandhi, MD, Timothy J. Kennedy, MD, H. Richard Alexander, MD, Darren R. Carpizo, MD, PhD, Russell C. Langan, MD
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Surgery Open Science
Online Access:http://www.sciencedirect.com/science/article/pii/S2589845020300336

Internet

http://www.sciencedirect.com/science/article/pii/S2589845020300336

Similar Items